Recombinant multi-species ZNF160 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZNF160 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a Kruppel-related zinc finger protein which is characterized by the presence of an N-terminal repressor domain, the Kruppel-associated box (KRAB). The KRAB domain is a potent repressor of transcription; thus this protein may function in transcription regulation. Multiple transcript variants have been found for this gene. [provided by RefSeq, Apr 2016]
The Alternative Names of target: F11,HKr18,HZF5,KR18,ZNF160,Zinc finger protein 160,Zinc finger protein HZF5,Zinc finger protein Kr18 (HKr18)

Target products collectionGo to ZNF160 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13408-Ag-1/ GM-Tg-hg-IP13408-Ag-2 Human ZNF160 protein Human
GM-Tg-rg-IP13408-Ag-1/ GM-Tg-rg-IP13408-Ag-2 Rat ZNF160 protein Rat
GM-Tg-mg-IP13408-Ag-1/ GM-Tg-mg-IP13408-Ag-2 Mouse ZNF160 protein Mouse
GM-Tg-cynog-IP13408-Ag-1/ GM-Tg-cynog-IP13408-Ag-2 Cynomolgus/Rhesus macaque ZNF160 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13408-Ag-1/ GM-Tg-felg-IP13408-Ag-2 Feline ZNF160 protein Feline
GM-Tg-cang-IP13408-Ag-1/ GM-Tg-cang-IP13408-Ag-2 Canine ZNF160 protein Canine
GM-Tg-bovg-IP13408-Ag-1/ GM-Tg-bovg-IP13408-Ag-2 Bovine ZNF160 protein Bovine
GM-Tg-equg-IP13408-Ag-1/ GM-Tg-equg-IP13408-Ag-2 Equine ZNF160 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13408-Ag-1/ GM-Tg-hg-IP13408-Ag-2; GM-Tg-rg-IP13408-Ag-1/ GM-Tg-rg-IP13408-Ag-2;
GM-Tg-mg-IP13408-Ag-1/ GM-Tg-mg-IP13408-Ag-2; GM-Tg-cynog-IP13408-Ag-1/ GM-Tg-cynog-IP13408-Ag-2;
GM-Tg-felg-IP13408-Ag-1/ GM-Tg-felg-IP13408-Ag-2; GM-Tg-cang-IP13408-Ag-1/ GM-Tg-cang-IP13408-Ag-2;
GM-Tg-bovg-IP13408-Ag-1/ GM-Tg-bovg-IP13408-Ag-2; GM-Tg-equg-IP13408-Ag-1/ GM-Tg-equg-IP13408-Ag-2
Products Name ZNF160 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ZNF160
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZNF160 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.